Monday, June 30, 2008

The end of quarter news rush

Many of my portfolio companies released news this morning, as the second quarter draws to a close. This includes items from biotech, such as Phase 2b data from TorreyPines Therapeutics (1.7% of portfolio), which upon a first reading, seems quite positive. Also Isis Pharmaceuticals (calls 1.5% of portfolio), which will receive payments for licensed technology. Other sectors are experiencing good news flow as well, such as True Religion (calls 4.7% of portfolio) in retail, which announced another store opening. Also technology, where Alvarion (calls 6.5% of portfolio) put out a press release regarding the first mobile WiMAX service in the United States. So despite the recent market turmoil, it's gratifying to see these companies advancing steadily toward their business goals over time.